1,234
Views
17
CrossRef citations to date
0
Altmetric
Report

Tissue TGF-β expression following conventional radiotherapy and pulsed low-dose-rate radiation

, , , , , ORCID Icon, , , & show all
Pages 1171-1174 | Received 29 Mar 2017, Accepted 03 Apr 2017, Published online: 12 May 2017

References

  • Richards GM, Tome WA, Robins HI, Stewart JA, Welsh JS, Mahler PA, Howard SP. Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region. Breast Cancer Res Treat 2009; 114:307-13; PMID:18389365; https://doi.org/10.1007/s10549-008-9995-3
  • Adkison JB, Tome W, Seo S, Richards GM, Robins HI, Rassmussen K, Welsh JS, Mahler PA, Howard SP. Reirradiation of large-volume recurrent glioma with pulsed reduced-dose-rate radiotherapy. Int J Radiat Oncol Biol Phys 2011; 79:835-41; PMID:20472350; https://doi.org/10.1016/j.ijrobp.2009.11.058
  • Ma CM, Lin MH, Dai XF, Koren S, Klayton T, Wang L, Li JS, Chen L, Price RA. Investigation of pulsed low dose rate radiotherapy using dynamic arc delivery techniques. Phys Med Biol 2012; 57:4613-26; PMID:22750648; https://doi.org/10.1088/0031-9155/57/14/4613
  • Lin MH, Price RA, Jr, Li J, Kang S, Li J, Ma CM. Investigation of pulsed IMRT and VMAT for re-irradiation treatments: dosimetric and delivery feasibilities. Phys Med Biol 2013; 58:8179-96; PMID:24200917; https://doi.org/10.1088/0031-9155/58/22/8179
  • Zhang P, Wang B, Chen X, Cvetkovic D, Chen L, Lang J, Ma CM. Local tumor control and normal tissue toxicity of pulsed low-dose rate radiotherapy for recurrent lung cancer: an in vivo animal study. Dose Response 2015; 13:1559325815588507; PMID:26675811
  • Joiner MC, Marples B, Lambin P, Short SC, Turesson I. Low-dose hypersensitivity: current status and possible mechanisms. Int J Radiat Oncol Biol Phys 2001; 49:379-89; PMID:11173131; https://doi.org/10.1016/S0360-3016(00)01471-1
  • Marples B, Collis SJ. Low-dose hyper-radiosensitivity: past, present, and future. Int J Radiat Oncol Biol Phys 2008; 70:1310-8; PMID:18374221; https://doi.org/10.1016/j.ijrobp.2007.11.071
  • Bedford JS, Mitchell JB. Dose-rate effects in synchronous mammalian cells in culture. Radiat Res 1973; 54:316-27; PMID:4735769; https://doi.org/10.2307/3573709
  • Yeoh EK, Krol R, Dhillon VS, Botten R, Di Matteo A, Butters J, Brock AR, Esterman A, Salisbury C, Fenech M. Predictors of radiation-induced gastrointestinal morbidity: A prospective, longitudinal study following radiotherapy for carcinoma of the prostate. Acta Oncologica 2016; 55:604-10; PMID:27046049; https://doi.org/10.3109/0284186X.2015.1118658
  • Lin PS, Wu A. Not all 2 Gray radiation prescriptions are equivalent: Cytotoxic effect depends on delivery sequences of partial fractionated doses. Int J Radiat Oncol Biol Phys 2005; 63:536-44; PMID:16168846; https://doi.org/10.1016/j.ijrobp.2005.06.010
  • Tome WA, Howard SP. On the possible increase in local tumour control probability for gliomas exhibiting low dose hyper-radiosensitivity using a pulsed schedule. Br J Radiol 2007; 80:32-7; PMID:16945935; https://doi.org/10.1259/bjr/15764945
  • Steel GG. The ESTRO Breur lecture. Cellular sensitivity to low dose-rate irradiation focuses the problem of tumour radioresistance. Radiother Oncol 1991; 20:71-83
  • Finnberg N, Gruber JJ, Fei P, Rudolph D, Bric A, Kim SH, Burns TF, Ajuha H, Page R, Wu GS, et al. DR5 knockout mice are compromised in radiation-induced apoptosis. Mol Cell Biol 2005; 25:2000-13; PMID:15713653; https://doi.org/10.1128/MCB.25.5.2000-2013.2005
  • Fleenor CJ, Higa K, Weil MM, DeGregori J. Evolved cellular mechanisms to respond to genotoxic insults: implications for radiation-induced hematologic malignancies. Radiat Res 2015; 184:341-51; PMID:26414506; https://doi.org/10.1667/RR14147.1
  • Fei P, Bernhard EJ, El-Deiry WS. Tissue-specific induction of p53 targets in vivo. Cancer Res 2002; 62:7316-27; PMID:12499275
  • Okunieff P, Chen Y, Maguire DJ, Huser AK. Molecular markers of radiation-related normal tissue toxicity. Cancer Metastasis Rev 2008; 27:363-74; PMID:18506399; https://doi.org/10.1007/s10555-008-9138-7
  • Kong FM, Zhao L, Hayman JA. The role of radiation therapy in thoracic tumors. Hematol Oncol Clin North Am 2006; 20:363-400; PMID:16730299; https://doi.org/10.1016/j.hoc.2006.01.021
  • Roeder F, Friedrich J, Timke C, Kappes J, Huber P, Krempien R, Debus J, Bischof M. Correlation of patient-related factors and dose-volume histogram parameters with the onset of radiation pneumonitis in patients with small cell lung cancer. Strahlenther Onkol 2010; 186:149-56; PMID:20165822; https://doi.org/10.1007/s00066-010-2018-4
  • Finnberg N, Klein-Szanto AJ, El-Deiry WS. TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis. J Clin Invest 2008; 118:111-23; PMID:18079962; https://doi.org/10.1172/JCI29900
  • Dadrich M, Nicolay NH, Flechsig P, Bickelhaupt S, Hoeltgen L, Roeder F, Hauser K, Tietz A, Jenne J, Lopez R, et al. Combined inhibition of TGFbeta and PDGF signaling attenuates radiation-induced pulmonary fibrosis. Oncoimmunology 2016; 5:e1123366; PMID:27467922; https://doi.org/10.1080/2162402X.2015.1123366

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.